Hint mode is switched on Switch off
For swift navigation between sections

BioNexus Gene Lab
LEI 549300COYSKRA3Z7E531

PDF download

Choose all Reset all
Download Cancel
Organization name
BioNexus Gene Lab Corp
Country name
Malaysia
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

BioNexus Gene Lab Corp. operates as a genome screening company. The Company focuses on developing non-invasive liquid biopsy tests for the early detection of disease risks derived from evidence-based research to minimize treatment costs and improve patient management on his current health status. BioNexus Gene Lab serves customers worldwide.

Awards

News

11/03/2026 BioNexus Gene Lab: Regulation Fd Disclosure, Other Events, Financial Statement And Exhibits
28/01/2026 BioNexus Gene Lab: – Other Events, Financial Statement And Exhibits
19/12/2025 BioNexus Gene Lab: Other Events
12/11/2025 BioNexus Gene Lab: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statement And Exhibits
07/11/2025 BioNexus Gene Lab: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statement And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300COYSKRA3Z7E531
  • SIC
    8071 SERVICES-MEDICAL LABORATORIES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001737523
  • EIN
    26-2124961
Registration is required to get access.